November Private Market UpdateThe private market one year past the peak - down, not out
November Private Market Update
EverlyWell was founded in 2014 by Julia Cheek. In 2021, parent company Everly Health hired two experienced financial executives, bringing on Chris Bishko as CFO and Kristina Omari as VP of Finance. Omari helped guide Lyft through an IPO in 2019. When asked about an IPO, Cheek told Bizjournals that she was "excited about the future of Everly Health and the opportunity to grow to serve even more Americans — certainly, these appointments positions us to do so." These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.
EverlyWell describes itself as "a consumer health testing company that connects people with accessible, innovative, and insightful at-home lab tests." In 2021 the company acquired Everly Health Solutions and Home Access Health. EverlyWell has received over $330 million in funding from investors including HealthQuest Capital, Morningside Ventures, Lux Capital, The Chernin Group, and Next Coast Ventures. A recent round of funding brought in $175 million and resulted in a $1.3 billion post-money valuation — a significant increase from the previous year.
Everly Health does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.
The stock price for Everly Health will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).
| Date | Funding Round | Funding Raised | Price per Share | IPO Valuation |
|---|---|---|---|---|
| 12/27/2021 | Series F | $154.68MM raised | $XXX.XX | $XXX.XX |
| 3/23/2021 | Series E | $192.92MM raised | $XXX.XX | $XXX.XX |
| 12/3/2020 | Series D | $258.1MM raised | $XXX.XX | $XXX.XX |
| 2/21/2020 | Series C | $25MM raised | $XXX.XX | $XXX.XX |
| 4/16/2019 | Series B | $29.63MM raised | $XXX.XX | $XXX.XX |
| 12/28/2017 | Series A and A-1 | $10.62MM raised | $XXX.XX | $XXX.XX |
| 4/19/2016 | Series Seed | $3.14MM raised | $XXX.XX | $XXX.XX |
